Zephyrnet Logo

Tag: Breast cancer

AstraZeneca and Daiichi’s next cancer medicine scores in breast tumors

Dive Brief: A new cancer drug developed by Daiichi Sankyo and AstraZeneca met one of its two main goals in a breast cancer trial, helping...

Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial,...

Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics – Nature Nanotechnology

de Magalhaes, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357–365 (2013).Article  Google Scholar  Laconi, E., Marongiu, F. & DeGregori,...

Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy – Nature Nanotechnology

Elia, I. & Haigis, M. C. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat. Metab. 3, 21–32 (2021).Article  Google...

Hope for patients with life-threatening muscle disorder after years of clinical trial failures

Duchenne muscular dystrophy (DMD) is a rare condition that is typically treated with the help of steroids, to manage symptoms, as scientists are yet...

Alotta Money Tribute Exhibition & Auction: Where Art, Technology, and Philanthropy Converge in Unprecedented Harmony | NFT CULTURE | NFT News | Web3 Culture...

The Details Trevor Jones is hosting his 2nd Annual Bitcoin Angel Party in France from September 3 to 5th, 2023 In memory of the late OG...

Beyond Biotech podcast 59 – World Lung Cancer Day

Since its inception in 2012, World Lung Cancer Day has been observed every year on August 1 in order to raise awareness of lung...

ICRS 2023: Report from Toronto | Project CBD

I counted over 175 talks and posters at the 33rd annual gathering of the International Cannabinoid Research Society (ICRS), which convened in Toronto at...

Why everything you thought you knew about femtech is wrong | EU-Startups

The term “femtech” was coined by Ida Tin, the founder of Clue, in 2016. It now represents an industry that is estimated to be worth $1 trillion by...

Nanotechnology’s triple threat: Advancing precision cancer treatment

In a recent review published in Natures Signal Transduction and Targeted Therapy Journal, a group of authors explored current and future strategies in the...

Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery – Gene Therapy

Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active...

Top biotech books of all time

It’s summertime and what’s better than to curl up in bed, or under a shady tree, or by the pool, and read a good...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?